These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 20960953)

  • 1. [Recurrent herpes simplex labialis infections. Possible prevention with a new therapeutic regimen].
    Harmenberg J; Spruance S
    Lakartidningen; 2010 Aug 25-31; 107(34):1918-22. PubMed ID: 20960953
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic options for herpes labialis, I: Oral agents.
    Elish D; Singh F; Weinberg JM
    Cutis; 2004 Jul; 74(1):31-4. PubMed ID: 15293697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent herpes simplex labialis: selected therapeutic options.
    Raborn GW; Grace MG
    J Can Dent Assoc; 2003 Sep; 69(8):498-503. PubMed ID: 12954137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical inquiries. What are the best treatments for herpes labialis?
    Chon T; Nguyen L; Elliott TC
    J Fam Pract; 2007 Jul; 56(7):576-8. PubMed ID: 17605952
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness of topical corticosteroids in addition to antiviral therapy in the management of recurrent herpes labialis: a systematic review and meta-analysis.
    Arain N; Paravastu SC; Arain MA
    BMC Infect Dis; 2015 Feb; 15():82. PubMed ID: 25887308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current management and recommendations for access to antiviral therapy of herpes labialis.
    Cunningham A; Griffiths P; Leone P; Mindel A; Patel R; Stanberry L; Whitley R
    J Clin Virol; 2012 Jan; 53(1):6-11. PubMed ID: 21889905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of topical 5% acyclovir and 1% hydrocortisone cream (Xerese™) in the treatment of recurrent herpes simplex labialis.
    Hull CM; Brunton S
    Postgrad Med; 2010 Sep; 122(5):1-6. PubMed ID: 20873400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent herpes simplex virus infection. Suppressive, reactive, and preventive antiviral regimens.
    Guerriere-Kovach PM; Brodell RT
    Postgrad Med; 2000 May; 107(6):139-40, 143, 147. PubMed ID: 10865873
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral antivirals for the acute treatment of recurrent herpes labialis.
    Jensen LA; Hoehns JD; Squires CL
    Ann Pharmacother; 2004 Apr; 38(4):705-9. PubMed ID: 14966254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial.
    Hull C; McKeough M; Sebastian K; Kriesel J; Spruance S
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):263-7. PubMed ID: 19143902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies.
    Baker D; Eisen D
    Cutis; 2003 Mar; 71(3):239-42. PubMed ID: 12661753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for short-course therapies in herpes genitalis and herpes labialis.
    Corey L; Stanberry L
    Herpes; 2007 Jun; 14 Suppl 1():4A. PubMed ID: 17877885
    [No Abstract]   [Full Text] [Related]  

  • 13. Topical treatment of recurrent herpes labialis.
    Pedersen A
    Oral Dis; 2001 Jan; 7(1):1. PubMed ID: 11354913
    [No Abstract]   [Full Text] [Related]  

  • 14. Topical and systemic therapies for oral and perioral herpes simplex virus infections.
    Stoopler ET; Balasubramaniam R
    J Calif Dent Assoc; 2013 Apr; 41(4):259-62. PubMed ID: 23705241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and tolerability of combination acyclovir 5% and hydrocortisone 1% cream in adolescents with recurrent herpes simplex labialis.
    Strand A; Böttiger D; Gever LN; Wheeler W
    Pediatr Dermatol; 2012; 29(1):105-10. PubMed ID: 22004219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes labialis.
    Worrall G
    Clin Evid; 2002 Jun; (7):1513-8. PubMed ID: 12230767
    [No Abstract]   [Full Text] [Related]  

  • 17. Early treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: a randomized, double-blind, placebo-controlled, patient-initiated clinical trial.
    Hull CM; Harmenberg J; Arlander E; Aoki F; Bring J; Darpö B; Levin MJ; Tyring S; Spruance SL;
    J Am Acad Dermatol; 2011 Apr; 64(4):696.e1-11. PubMed ID: 20851499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Topical 5% Acyclovir-1% Hydrocortisone Cream (ME-609) for Treatment of Herpes Labialis: a systematic review.
    Rosa MI; Souza SL; Farias BF; Pires PD; Dondossola ER; dos Reis ME
    An Acad Bras Cienc; 2015 Aug; 87(2 Suppl):1415-20. PubMed ID: 26247156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aciclovir + hydrocortisone. Herpes labialis: a topical antiviral drug perhaps, but not a steroid.
    Prescrire Int; 2011 Sep; 20(119):205-7. PubMed ID: 21954513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of antiviral agents for the prevention of recurrent herpes labialis: a systematic review and meta-analysis.
    Rahimi H; Mara T; Costella J; Speechley M; Bohay R
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 May; 113(5):618-27. PubMed ID: 22668620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.